Exclusive Review Papers in Cellular Metabolism: From Basic to Clinical Metabolic Research

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Metabolism".

Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 1431

Special Issue Editor


E-Mail Website1 Website2
Guest Editor
Department of Physiology, Medical University of Bialystok, Mickiewicza 2C Street, 15-222 Bialystok, Poland
Interests: obesity; mesenchymal stem cells; insulin resistance; diabetes mellitus; cardiovascular diseases; adipocytes; skeletal muscle; metabolic syndrome; lipid metabolism; fatty acid handling proteins, cellular metabolism
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cellular metabolism plays a crucial role in all living organisms, and it is based on the interplay of many genes, proteins, and metabolites. Evidently numerous human diseases stem from perturbations of homeostasis that lead to severe tissue dysfunction.

This Special Issue aims to provide a comprehensive overview of cell metabolism underlying physiological homeostasis and disturbances thereof in pathological conditions in different cells, organs, and systems. Authors are invited to submit review articles, meta-analyses and systematic reviews with new insights into cellular and molecular homeostatic processes. These include, but are not limited to, mesenchymal stem cell biology, adipose tissue biology, cardiovascular biology, pancreatic beta cell function, mitochondria and other metabolic organelles biology, glucose metabolism, lipid metabolism, and exercise metabolism. Submissions related to both existing and future therapies for metabolic disease (e.g., type 1 and 2 diabetes, cardiovascular disease, obesity, lipid disorders) are also welcome.

Dr. Agnieszka Mikłosz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cell metabolism
  • mesenchymal stem cell biology
  • adipose tissue biology
  • cardiovascular biology
  • pancreatic beta cell function
  • glucose metabolism
  • lipid metabolism
  • exercise metabolism
  • obesity
  • type 2 diabetes mellitus
  • metabolic syndrome

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

30 pages, 2334 KiB  
Review
Receptors and Signaling Pathways Controlling Beta-Cell Function and Survival as Targets for Anti-Diabetic Therapeutic Strategies
by Stéphane Dalle and Amar Abderrahmani
Cells 2024, 13(15), 1244; https://doi.org/10.3390/cells13151244 - 24 Jul 2024
Viewed by 817
Abstract
Preserving the function and survival of pancreatic beta-cells, in order to achieve long-term glycemic control and prevent complications, is an essential feature for an innovative drug to have clinical value in the treatment of diabetes. Innovative research is developing therapeutic strategies to prevent [...] Read more.
Preserving the function and survival of pancreatic beta-cells, in order to achieve long-term glycemic control and prevent complications, is an essential feature for an innovative drug to have clinical value in the treatment of diabetes. Innovative research is developing therapeutic strategies to prevent pathogenic mechanisms and protect beta-cells from the deleterious effects of inflammation and/or chronic hyperglycemia over time. A better understanding of receptors and signaling pathways, and of how they interact with each other in beta-cells, remains crucial and is a prerequisite for any strategy to develop therapeutic tools aimed at modulating beta-cell function and/or mass. Here, we present a comprehensive review of our knowledge on membrane and intracellular receptors and signaling pathways as targets of interest to protect beta-cells from dysfunction and apoptotic death, which opens or could open the way to the development of innovative therapies for diabetes. Full article
Show Figures

Figure 1

Back to TopTop